Liver Fibrosis Markers Improve Prediction of Outcome in Non‐Acetaminophen‐Associated Acute Liver Failure

Liver Fibrosis Markers Improve Prediction of Outcome in Non‐Acetaminophen‐Associated Acute Liver Failure

A prognostic system for acute liver failure (ALF) with a higher predictive value is urgently needed. The role of extracellular matrix (ECM) remodeling in ALF has not been fully elucidated. We hypothesized that serologic fibrosis markers, which reflect ECM remodeling, are predictive of ALF outcome at...

Full description

Bibliographic Details
Main Authors:	Aya Ugamura, Po‐sung Chu, Nobuhiro Nakamoto, Nobuhito Taniki, Keisuke Ojiro, Taizo Hibi, Masahiro Shinoda, Hideaki Obara, Yohei Masugi, Akihiro Yamaguchi, Shunsuke Shiba, Rei Morikawa, Shingo Usui, Hirotoshi Ebinuma, Yuko Kitagawa, Hidetsugu Saito, Takanori Kanai
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2018-11-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1233

Similar Items

CLIF‐C Organ Failure Score and Liver Volume Predict Prognosis in Steroid‐Treated Severe Acute Autoimmune Hepatitis
by: Akihiko Ikura, et al.
Published: (2020-07-01)

Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
by: Hitomi Hoshi, et al.
Published: (2021-01-01)

Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study
by: Shunsuke Shiba, et al.
Published: (2020-03-01)

Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis
by: Shingo Usui, et al.
Published: (2017-10-01)

On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.
by: Po-Sung Chu, et al.
Published: (2017-01-01)

The gut-liver axis in hepatobiliary diseases
by: Masataka Ichikawa, et al.
Published: (2024-01-01)

Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.
by: Po-sung Chu, et al.
Published: (2015-01-01)

Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice
by: Nobuhiro Nakamoto, et al.
Published: (2017-10-01)

Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts.
by: Karin Yamataka, et al.
Published: (2022-01-01)

Macrophages and dendritic cells emerge in the liver during intestinal inflammation and predispose the liver to inflammation.
by: Yohei Mikami, et al.
Published: (2014-01-01)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
by: Takumi Hirata, et al.
Published: (2013-01-01)

Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis
by: Yoichi Takimoto, et al.
Published: (2023-03-01)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
by: Takumi Hirata, et al.
Published: (2014-01-01)

Role of Toll-like receptors in immune activation and tolerance in the liver
by: Nobuhiro eNakamoto, et al.
Published: (2014-05-01)

Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
by: Akihiro Yamaguchi, et al.
Published: (2021-09-01)

Acetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption
by: Shunsuke Shiba, et al.
Published: (2021-07-01)

CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury
by: Yuzo Koda, et al.
Published: (2022-09-01)

Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma
by: Ryosuke Kasuga, et al.
Published: (2024-05-01)

CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells
by: Yuzo Koda, et al.
Published: (2021-07-01)

Laparoscopic repeat liver resection after open liver resection: A comparative study from a single-centre
by: Taiga Wakabayashi, et al.
Published: (2020-01-01)

Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis
by: Shoji Yamada, et al.
Published: (2017-11-01)

Advances in the study of acetaminophen-induced liver injury
by: Xinghui Li, et al.
Published: (2023-08-01)

Interleukin-10 disrupts liver repair in acetaminophen-induced acute liver failure
by: Katherine Roth, et al.
Published: (2023-11-01)

Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice
by: Tingting Zhai, et al.
Published: (2023-04-01)

Focal Update on Immunotherapy and Liver Transplantation in the Era of Transplant Oncology
by: Maen Abdelrahim, et al.
Published: (2024-08-01)

Delayed Acetaminophen Absorption Resulting in Acute Liver Failure
by: Huiling Tan, et al.
Published: (2022-01-01)

PULMONARY AND LIVER DAMAGE DURING TREATMENT WITH ACETAMINOPHEN (PARACETAMOL)
by: L. I. Dvoretski, et al.
Published: (2016-08-01)

Targeting Autophagy for Acetaminophen-Induced Liver Injury: An Update
by: Kaitlyn Hinz, et al.
Published: (2024-08-01)

Effect of Fructose in Acetaminophen Induced Liver Injury in Rats
by: Fareeha Farooq, et al.
Published: (2010-08-01)

Effect of Fructose in Acetaminophen Induced Liver Injury in Rats
by: Fareeha Farooq, et al.
Published: (2010-08-01)

Corrigendum: Advances in the study of acetaminophen-induced liver injury
by: Xinghui Li, et al.
Published: (2023-09-01)

Mitochondrial damage and biogenesis in acetaminophen-induced liver injury
by: Hartmut Jaeschke, et al.
Published: (2019-12-01)

Effect of Fructose in Acetaminophen Induced Liver Injury in Rats
by: Fareeha Farooq, et al.
Published: (2010-01-01)

Acetaminophen-induced microvascular injury in the rat liver: protection with misoprostol
by: Lim, S.P., et al.
Published: (1996)

A dual role of inflammation in acetaminophen-induced liver injury
by: Long Xu, et al.
Published: (2023-03-01)

Fisetin Prevents Acetaminophen-Induced Liver Injury by Promoting Autophagy
by: Jiaqi Zhang, et al.
Published: (2020-02-01)

"Nifedipine in the treatment of liver toxicity induced by Acetaminophen overdose in mice "
by: Kalantari H, et al.
Published: (2000-12-01)

Use of acetylcysteine for non-acetaminophen-induced acute liver failure
by: Ibrahim Sales, et al.
Published: (2013-01-01)

The effect of acetaminophen nanoparticles on liver toxicity in a rat model
by: Esmaeil Biazar, et al.
Published: (2010-03-01)

"Nifedipine in the treatment of liver toxicity induced by Acetaminophen overdose in mice "
by: Kalantari H, et al.
Published: (2000-11-01)